Quiz

Article

Clinical Quiz: HCV DAA Treatment After Solid Organ Transplantation

This clinical quiz will test your knowledge of the 2023 American Association for the Study of Liver Diseases/Infectious Diseases Society of America Hepatitis C guideline.

Clinician and liver | Credit: Pixabay

Credit: Pixabay

Since 2013, the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases have worked together to develop evidence-based guidance for the diagnosis, management, and treatment of hepatitis C virus (HCV) infection.

This update to the previous 2020 guidelines was released in 2023 and reflects our current understanding of the infection with timely, evidence-based guidance spotlighting major changes related to screening, organ transplantation, and expanded treatment options for children and adolescents.

Test your knowledge of the 2023 HCV guidance update below:

When should treatment be initiated for HCV-uninfected recipients of liver grafts from HCV-viremic donors using glecaprevir/pibrentasvir?


Reference:

  1. Bhattacharya D, Aronsohn A, Price J, Lo Re V; AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. Published online May 25, 2023. doi:10.1093/cid/ciad319

Editors' note: Artificial intelligence aided in the creation of this content.

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
4 experts are featured in this series.
4 experts are featured in this series.
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.